Abiraterone-acetate

General

Type : Pro-Drug || Drug || Pyridine || Not A\/B H target || Phenanthrene

Chemical_Nomenclature : [(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate

Canonical SMILES : CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CC=C4C5=CN=CC=C5)C)C

InChI : InChI=1S\/C26H33NO2\/c1-17(28)29-20-10-12-25(2)19(15-20)6-7-21-23-9-8-22(18-5-4-14-27-16-18)26(23,3)13-11-24(21)25\/h4-6,8,14,16,20-21,23-24H,7,9-13,15H2,1-3H3\/t20-,21-,23-,24-,25-,26+\/m0\/s1

InChIKey : UVIQSJCZCSLXRZ-UBUQANBQSA-N

Other name(s) : Abiraterone acetate,     Zytiga,     CB7630,     Yonsa,     CHEBI:68639,     CHEMBL271227,     SCHEMBL93715


MW : 391.5

Formula : C26H33NO2

CAS_number : 154229-18-2

PubChem :

UniChem :

Iuphar :

Target

References (4)

Title : Role of Silica Intrawall Microporosity on Abiraterone Acetate Solubilization and In Vivo Oral Absorption - Almasri_2022_Mol.Pharm_19_1091
Author(s) : Almasri R , Schultz HB , Moller A , Bremmell KE , Garcia-Bennett A , Joyce P , Prestidge CA
Ref : Mol Pharm , 19 :1091 , 2022
Abstract : Almasri_2022_Mol.Pharm_19_1091
ESTHER : Almasri_2022_Mol.Pharm_19_1091
PubMedSearch : Almasri_2022_Mol.Pharm_19_1091
PubMedID: 35238208

Title : Arylacetamide deacetylase as a determinant of the hydrolysis and activation of abiraterone acetate in mice and humans - Sakai_2021_Life.Sci_284_119896
Author(s) : Sakai Y , Fukami T , Nagaoka M , Hirosawa K , Ichida H , Sato R , Suzuki K , Nakano M , Nakajima M
Ref : Life Sciences , 284 :119896 , 2021
Abstract : Sakai_2021_Life.Sci_284_119896
ESTHER : Sakai_2021_Life.Sci_284_119896
PubMedSearch : Sakai_2021_Life.Sci_284_119896
PubMedID: 34450168
Gene_locus related to this paper: mouse-aryla

Title : Investigations of the mechanism behind the rapid absorption of nano-amorphous abiraterone acetate - Basa-Denes_2019_Eur.J.Pharm.Sci_129_79
Author(s) : Basa-Denes O , Solymosi T , Otvos Z , Angi R , Ujhelyi A , Jordan T , Heltovics G , Glavinas H
Ref : Eur J Pharm Sci , 129 :79 , 2019
Abstract : Basa-Denes_2019_Eur.J.Pharm.Sci_129_79
ESTHER : Basa-Denes_2019_Eur.J.Pharm.Sci_129_79
PubMedSearch : Basa-Denes_2019_Eur.J.Pharm.Sci_129_79
PubMedID: 30610953

Title : Rapid conversion of the ester prodrug abiraterone acetate results in intestinal supersaturation and enhanced absorption of abiraterone: in vitro, rat in situ and human in vivo studies - Stappaerts_2015_Eur.J.Pharm.Biopharm_90_1
Author(s) : Stappaerts J , Geboers S , Snoeys J , Brouwers J , Tack J , Annaert P , Augustijns P
Ref : Eur J Pharm Biopharm , 90 :1 , 2015
Abstract : Stappaerts_2015_Eur.J.Pharm.Biopharm_90_1
ESTHER : Stappaerts_2015_Eur.J.Pharm.Biopharm_90_1
PubMedSearch : Stappaerts_2015_Eur.J.Pharm.Biopharm_90_1
PubMedID: 25592324